Abstract

PICO question
 Does use of dog-appeasing pheromone reduce the frequency and/or severity of non-specific stress behaviours associated with anxiety in domestic dogs, older than 6 months, when compared with no treatment?
 
 Clinical bottom line
 Category of research question
 Treatment
 The number and type of study designs reviewed
 Eight controlled trials were appraised. Four were randomised and four were either non-randomised or did not clearly describe the method of allocating subjects into treatment groups.
 Strength of evidence
 Weak
 Outcomes reported
 There was no evidence that any dog appeasing pheromone (DAP) formulation (spray, diffuser, or collar) was superior. There was moderate evidence that DAP could reduce some behavioural manifestations of fear and/or anxiety stemming from thunderstorm noise and weak evidence that it could ameliorate some non-specific stress behaviours in hospitalised patients. In shelter dogs, there was mild evidence that DAP could reduce barking intensity and increase some behaviours associated with relaxation. When behavioural changes occurred, most were observed during exposure to DAP and there were minimal residual effects post-treatment.
 Conclusion
 The evidence for using DAP to manage stress behaviours associated with anxiety in dogs over six months of age remains weak. Until there is a stronger evidentiary basis, clinicians should be aware that a true clinical benefit is undetermined. Nevertheless, DAP is unlikely to cause harm and may still provide some therapeutic benefit. Therefore, DAP may still be employed in a multimodal management plan for some behaviour cases and may exert a placebo effect. However, if an owner’s financial resources are restrictive, clinicians should not prioritise pheromone therapy at the omission of other therapies that have established clinical effects
 
 How to apply this evidence in practice
 The application of evidence into practice should take into account multiple factors, not limited to: individual clinical expertise, patient’s circumstances and owners’ values, country, location or clinic where you work, the individual case in front of you, the availability of therapies and resources.
 Knowledge Summaries are a resource to help reinforce or inform decision making. They do not override the responsibility or judgement of the practitioner to do what is best for the animal in their care.
 

Highlights

  • ‘Condition B’: subject remained in the laboratory in the absence of their owner/familiar person for 30 minutes with Dog-appeasing pheromone (DAP) diffusers switched on or off

  • No significant effect of DAP application was found on exploration and locomotion

  • There was no significant effect of DAP application on barking, scratching, whining, or passive behaviour following the Bonferroni correction

Read more

Summary

Conclusion

The evidence for using DAP to manage stress behaviours associated with anxiety in dogs over six months of age remains weak. In those studies that investigated a DAP-infused collar, the most well-designed (Broach & Dunham, 2016) assessed its application for 7 month old Belgian Malinois dogs transitioning to a military kennel This was a double-blinded, randomised and placebo-controlled trial, the generation of the random allocation sequence was not described. The third study (Grigg & Piehler, 2015) assessed the impact of DAP collar on stress-related behaviours in dogs housed in a teaching kennel environment This was a randomised controlled trial; the randomisation technique was not described, the sample size was small (n = 8), a placebo was not employed, and it was unclear if caregivers were blinded. It is unclear if the DAP diffuser was used as per the manufacturer’s instructions

Summary of the evidence
Limitations:
Findings
Methodology Section

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.